K-ras and p53 mutations in lung cancer
Author Information
Author(s): Y Fukuyama, T Mitsudomi, K Sugio, T Ishida, K Akazawa, K Sugimachi
Primary Institution: Kyushu University
Hypothesis
Are K-ras and p53 mutations independent prognostic indicators in non-small-cell lung cancer?
Conclusion
K-ras and p53 mutations are independent unfavourable prognostic markers, especially in early-stage non-small-cell lung cancer.
Supporting Evidence
- 11 patients (6.9%) had K-ras mutations.
- 57 patients (35.8%) had p53 mutations.
- Ras+ patients had a worse prognosis than ras- patients.
- P53+ patients had a worse prognosis in early-stage cases.
- Both mutations were independent prognostic factors according to Cox's model.
Takeaway
This study found that certain gene mutations can make lung cancer worse, especially if the cancer is caught early.
Methodology
The study examined 159 patients for K-ras mutations at codon 12 and p53 mutations in exons 5-8, analyzing their correlation with patient prognosis.
Potential Biases
Potential selection bias as the study included only consecutive patients from a single institution.
Limitations
The study may not account for all genetic factors influencing prognosis due to the focus on only K-ras and p53 mutations.
Participant Demographics
159 Japanese patients, 103 men and 56 women, ages 35 to 82 (median 65 years).
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website